CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea · Delayed Price · Currency is KRW 1,858.00
-4.00 (-0.21%)
Dec 30, 2025, 3:30 PM KST
CMG Pharmaceutical Market Cap
CMG Pharmaceutical has a market cap or net worth of 274.69 billion as of December 30, 2025. Its market cap has increased by 3.76% in one year.
Market Cap
274.69B
Enterprise Value
305.50B
Revenue
100.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,858.00
Market Cap Chart
Since March 1, 2002, CMG Pharmaceutical's market cap has increased from 11.27B to 274.69B, an increase of 2,337.41%. That is a compound annual growth rate of 14.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 275.28B | 12.10% |
| Dec 30, 2024 | 245.56B | -26.64% |
| Dec 28, 2023 | 334.73B | 12.09% |
| Dec 29, 2022 | 298.62B | -43.94% |
| Dec 30, 2021 | 532.65B | -33.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 23.48T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.06T |